Siqi Yuan1,2, Yao Fang3, Mengling Tang1,2, Zhiqiang Hu1, Chenglong Rao1, Jiangao Chen1,4, Yupei Xia1, Meijuan Zhang1, Jingmin Yan1, Bin Tang1, Xiaoyi He1, Jianping Xie2, Xuhu Mao1, Qian Li5. 1. Department of Clinical Microbiology and Immunology, College of Pharmacy and Medical Laboratory, Army Medical University (Third Military Medical University), Chongqing, 400038, China. 2. Institute of Modern Biopharmaceuticals, State Key Laboratory Breeding Base of Eco-Environment and Bio-Resource of the Three Gorges Area, Key Laboratory of Eco-environments in Three Gorges Reservoir Region, Ministry of Education, School of Life Sciences, Southwest University, Beibei, Chongqing, 400715, China. 3. Department of Respiratory, General Hospital of Center Theater Command, Wuhan, 400070, China. 4. Department of General Medicine, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, 400038, China. 5. Department of Clinical Microbiology and Immunology, College of Pharmacy and Medical Laboratory, Army Medical University (Third Military Medical University), Chongqing, 400038, China. liqianjane@163.com.
Abstract
BACKGROUND: Burkholderia pseudomallei, a facultative intracellular bacterium, is the aetiological agent of melioidosis that is responsible for up to 40% sepsis-related mortality in epidemic areas. However, no effective vaccine is available currently, and the drug resistance is also a major problem in the treatment of melioidosis. Therefore, finding new clinical treatment strategies in melioidosis is extremely urgent. RESULTS: We demonstrated that tauroursodeoxycholic acid (TUDCA), a clinically available endoplasmic reticulum (ER) stress inhibitor, can promote B. pseudomallei clearance both in vivo and in vitro. In this study, we investigated the effects of TUDCA on the survival of melioidosis mice, and found that treatment with TUDCA significantly decreased intracellular survival of B. pseudomallei. Mechanistically, we found that B. pseudomallei induced apoptosis and activated IRE1 and PERK signaling ways of ER stress in RAW264.7 macrophages. TUDCA treatment could reduce B. pseudomallei-induced ER stress in vitro, and TUDCA is protective in vivo. CONCLUSION: Taken together, our study has demonstrated that B. pseudomallei infection results in ER stress-induced apoptosis, and TUDCA enhances the clearance of B. pseudomallei by inhibiting ER stress-induced apoptosis both in vivo and in vitro, suggesting that TUDCA could be used as a potentially alternative treatment for melioidosis.
BACKGROUND:Burkholderia pseudomallei, a facultative intracellular bacterium, is the aetiological agent of melioidosis that is responsible for up to 40% sepsis-related mortality in epidemic areas. However, no effective vaccine is available currently, and the drug resistance is also a major problem in the treatment of melioidosis. Therefore, finding new clinical treatment strategies in melioidosis is extremely urgent. RESULTS: We demonstrated that tauroursodeoxycholic acid (TUDCA), a clinically available endoplasmic reticulum (ER) stress inhibitor, can promote B. pseudomallei clearance both in vivo and in vitro. In this study, we investigated the effects of TUDCA on the survival of melioidosismice, and found that treatment with TUDCA significantly decreased intracellular survival of B. pseudomallei. Mechanistically, we found that B. pseudomallei induced apoptosis and activated IRE1 and PERK signaling ways of ER stress in RAW264.7 macrophages. TUDCA treatment could reduce B. pseudomallei-induced ER stress in vitro, and TUDCA is protective in vivo. CONCLUSION: Taken together, our study has demonstrated that B. pseudomallei infection results in ER stress-induced apoptosis, and TUDCA enhances the clearance of B. pseudomallei by inhibiting ER stress-induced apoptosis both in vivo and in vitro, suggesting that TUDCA could be used as a potentially alternative treatment for melioidosis.
Authors: Umut Ozcan; Erkan Yilmaz; Lale Ozcan; Masato Furuhashi; Eric Vaillancourt; Ross O Smith; Cem Z Görgün; Gökhan S Hotamisligil Journal: Science Date: 2006-08-25 Impact factor: 47.728
Authors: Ihab H Hassan; Michael S Zhang; Linda S Powers; Jian Q Shao; Jonas Baltrusaitis; D Thomas Rutkowski; Kevin Legge; Martha M Monick Journal: J Biol Chem Date: 2011-12-22 Impact factor: 5.157
Authors: Cecilia M P Rodrigues; Susana Sola; Zhenhong Nan; Rui E Castro; Paulo S Ribeiro; Walter C Low; Clifford J Steer Journal: Proc Natl Acad Sci U S A Date: 2003-04-29 Impact factor: 11.205
Authors: James E Heubi; David A Wiechmann; Vivian Creutzinger; Kenneth D R Setchell; Robert Squires; Robert Couser; Philip Rhodes Journal: J Pediatr Date: 2002-08 Impact factor: 4.406
Authors: Judith A Smith; Mike Khan; Diogo D Magnani; Jerome S Harms; Marina Durward; Girish K Radhakrishnan; Yi-Ping Liu; Gary A Splitter Journal: PLoS Pathog Date: 2013-12-05 Impact factor: 6.823
Authors: A E Elia; S Lalli; M R Monsurrò; A Sagnelli; A C Taiello; B Reggiori; V La Bella; G Tedeschi; A Albanese Journal: Eur J Neurol Date: 2015-02-09 Impact factor: 6.089